Human T lymphocytes possess both the type I and II isozymes of protein kinase A (PKA). The type I (PKA-I) isozyme is predominantly associated with the plasma membrane, whereas the type II (PKA-II) isozyme is primarily localized to the cytosol. Because the functions of both PKA-I and PKA-II isozymes in the biochemical events of T lymphocyte activation have not been clearly elucidated, we tested the hypothesis that very early events of normal human T lymphocyte activation are mediated by the PKA-I and/or PKA-II isozyme(s). Fresh normal human T cells and a normal human CD4+ T cell line (GK606) activated with anti-CD3-E and recombinant interleukin la (rIL-la) exhibited a peak six-to sevenfold increase of PKA phosphotransferase activity at 5 min that returned to baseline by 60 min. Similarly, both fresh T cells and the T cell line activated by phorbol myristate acetate and ionomycin demonstrated a peak eightfold increase of PKA activity by 15 min that returned toward baseline by 60 min. Chromatographic separation of the PKA isozymes and quantification of phosphotransferase activities after T cell activation by either agonist pair showed preferential activation of the PKA-I isozyme, resulting in a significant reduction in the ratio of PKA-I to PKA-II isozyme activity from 3.1:1-6.2:1 to 1.1:1-3.2:1. PKA-I isozyme activation resulted in the release of free catalytic (C) subunit, an increase in C subunit phosphotransferase activity, and the phosphorylation of T cell plasma membrane-associated proteins, p14, pl7, p20, p21, p38, and p48. However, activation of the PKA-I isozyme did not appear to be required for the transcription of IL-2 mRNA, an event necessary for mitosis. These data indicate that ligand-induced T cell activation is associated with rapid activation of the PKA-I, but not PKA-II, isozyme that results in phosphorylation of plasma membrane-associated proteins. The involvement of the PKA-I isozyme during the very early events of T cell activation suggests that this isozyme may be an antigen-or mitogen-stimulated protein kinase. (J. Clin. Invest. 1993.92:2207-2214
Introduction
Human T lymphocytes possess both the type I and II isozymes of protein kinase A (PKA). The type I (PKA-I) isozyme is predominantly associated with the plasma membrane, whereas the type II (PKA-II) isozyme is primarily localized to the cytosol. Because the functions of both PKA-I and PKA-II isozymes in the biochemical events of T lymphocyte activation have not been clearly elucidated, we tested the hypothesis that very early events of normal human T lymphocyte activation are mediated by the PKA-I and/or PKA-II isozyme(s). Fresh normal human T cells and a normal human CD4+ T cell line (GK606) activated with anti-CD3-E and recombinant interleukin la (rIL-la) exhibited a peak six-to sevenfold increase of PKA phosphotransferase activity at 5 min that returned to baseline by 60 min. Similarly, both fresh T cells and the T cell line activated by phorbol myristate acetate and ionomycin demonstrated a peak eightfold increase of PKA activity by 15 min that returned toward baseline by 60 min. Chromatographic separation of the PKA isozymes and quantification of phosphotransferase activities after T cell activation by either agonist pair showed preferential activation of the PKA-I isozyme, resulting in a significant reduction in the ratio of PKA-I to PKA-II isozyme activity from 3.1:1-6.2:1 to 1.1:1-3.2:1. PKA-I isozyme activation resulted in the release of free catalytic (C) subunit, an increase in C subunit phosphotransferase activity, and the phosphorylation of T cell plasma membrane-associated proteins, p14, pl7, p20, p21, p38, and p48. However, activation of the PKA-I isozyme did not appear to be required for the transcription of IL-2 mRNA, an event necessary for mitosis. These data indicate that ligand-induced T cell activation is associated with rapid activation of the PKA-I, but not PKA-II, isozyme that results in phosphorylation of plasma membrane-associated proteins. The involvement of the PKA-I isozyme during the very early events of T cell activation suggests that this isozyme may be an antigen-or mitogen-stimulated protein kinase. (J. Clin. Invest. 1993.92:2207-2214.) Key words: signal transduction * cAMP * protein kinases * lymphocytes -protein phosphorylation T lymphocyte activation encompasses a complex cascade of biochemical and molecular events resulting in the production oflymphokines, upregulation ofreceptors, and, ultimately, mitosis. This process entails: (a) apposition of the T cell to an antigen-presenting accessory cell, (b) presentation of an antigenic peptide bound to a class I or II major histocompatibility molecule to the T cell antigen receptor (TCR) (1) , (c) occupancy ofthe T cell interleukin 1 receptor (IL-l R) by IL-1 (2) , (d) a physical interaction between the T lymphocyte and accessory cell (3) , and (e) the subsequent actuation of a signal(s) that is conveyed to the nucleus. This biochemical signal(s) triggers the sequential transcription of multiple genes over time, including IL-2 (4, 5) . The primary phase ofT cell activation can be replicated in vitro by substituting monoclonal anti-CD3 antibody bound to a surface for antigen (6) in the presence of recombinant IL-la (rIL-la). Within several minutes ofoccupancy ofthe TCR/CD3 complex by anti-CD3, two families of protein kinases are activated. Protein kinase C (PKC) 1 phosphorylates multiple substrates, including the y and 6 chains ofCD3 (5, 7, 8) ; tyrosine protein kinases phosphorylate alternative substrates, including the ¢ chain of CD3 (9, 10) .
The role of protein kinase A (cAMP-dependent protein kinase, PKA; EC 2.7.1.37) in these early events of human T cell activation remains incompletely defined (1 1, 12) . This is not surprising, since the precise functions ofthe PKA-I and PKA-II isozymes in cell growth and differentiation are controversial. The PKA-I isozyme has been correlated with both cell growth and differentiation, depending upon the tissue analyzed ( 13) . Early analyses oflymphocyte mitogenesis stimulated by Concanavalin A found a predominant activation of the PKA-I isozyme after 4 h in culture ( 14) . More recently, the use of antisense oligonucleotides to alter the expression ofthe PKA type I regulatory (RI) and RII subunits in the human HL-60 promyelocytic leukemia cell line demonstrated that the a isoform of PKA-I was necessary to drive the cell's neoplastic growth ( 15) . Our demonstration that the PKA-I isozyme is predominantly localized to the plasma membrane of human T lymphocytes ( 12) cAMP-snducible, PKA-I isozyme-catalyzed protein phosphorylation. Normal T lymphocyte plasma membrane containing PKA-I isozyme activity was isolated as described ( 12) . cAMP-inducible, PKA-I isozyme-catalyzed phosphorylation of membrane-associated proteins was analyzed by one-dimensional PAGE ( 1D-PAGE) and autoradiography as described ( 18 7 .2], 1 mM EDTA, and 0.1 mM DTT). Separation of PKA-I and PKA-II isozymes was performed by tandem DE52-cellulose and CM-sephadex column chromatography. DE52-cellulose retains the holoenzymes; free C subunits pass through the DE52-cellulose column and are retained on the CM-sephadex column (20) . The DE52-cellulose column (bed volume, 1 ml; 0.8 cm X 4.3 cm) and CM-sephadex column (bed volume, 2 ml; 0.8 cm X 4.3 cm) were equilibrated with buffer B.
1 mg of cellular homogenate was loaded onto the DE52-cellulose column and rinsed with 10 ml ofbuffer B. The column was eluted with a continuous, linear gradient (0-0.4 M NaCl) established by mixing of 18 ml of buffer B plus 18 ml of buffer B containing 0.4 M NaCl. The flow rate was 0.2 ml/min, and the average duration ofelution was 3 h. Fractions (60 Ml) were assayed for PKA-I-and PKA-II-catalyzed phosphotransferase activity after addition of 10 MM cAMP. The addition of exogenous cAMP to the eluted isozyme is necessary in order to dissociate the R subunits from the C subunits, permitting activation of the isozyme and quantification of its phosphotransferase activity. The peak PKA-I isozyme activity eluted at fraction 11 and the peak PKA-II isozyme activity eluted at fraction 23. Free C subunit was eluted from a CM-sephadex column with buffer B containing 0.55 M NaCl (20) . C subunit phosphotransferase activity was quantified in the absence of cAMP. Total PKA-I and PKA-II phosphotransferase activities and free C subunit activity were obtained by summing the enzyme activities in each fraction for PKA-I, PKA-II, and C subunit and expressing the total activities as pmol/min.
The areas under the elution curves defining the PKA-I and PKA-II isozymes were quantified by a MOP-Videoplan image analysis system (Kontron-Bildanalyse). The ratio of PKA-I to PKA-II isozyme activity was calculated by dividing the area under the curve of PKA-I activity by the area under the curve of PKA-II activity ( 12) ; the mean activity ratio in these experiments was 4.0:1 (range, 3.1:1-6.2:1 ). A reduction in the ratio of PKA-I to PKA-II activity indicates endogenous cAMP-inducible activation and use of a portion of the PKA-I isozyme.
Protein concentrations. Protein concentrations were quantified by the method of Bradford (21 ) .
Message amplificationphenotyping (MAPPing) ofIL-2 and 3-actin mRNAs. We used the reverse transcriptase polymerase chain reaction (RT-PCR) to amplify the IL-2 and ,B-actin mRNAs. This technique identifies the presence or absence of these mRNAs, but does not quantify the transcripts.
Total RNA was isolated from 3 X 106 T lymphocytes (22) and quantified at OD 260. The RNA was used to synthesize single-stranded cDNA (sscDNA) essentially as described (23) . The cDNA mixture was diluted to 50 Ml with TE buffer ( 10 mM Tris-HCl [ pH 8.0 ], 1 mM EDTA), and 5 MAL was used in the amplification reaction with oligonucleotide primers specific for IL-2 and f3-actin gene message.
The IL-2 and f3-actin primers were obtained from Clontech (Palo Alto, CA). 5' and 3' primers were complementary to sequences in the first and last exons, respectively. The specificity of the amplified bands in each case was confirmed by their predicted sizes as well as by cloning and sequencing the PCR products. 
Results
Anti-CD3-e and rIL-Ia stimulates PKA phosphotransferase activity. Fresh human T cells or the quiescent, IL-2-dependent T cell line (GK606) were activated with the agonist pair, 10 ng/ ml anti-CD3-e and 50 U/ml rIL-1 a, for intervals to 60 min. When this agonist pair was used, both fresh T lymphocytes and the GK606 line transcribed IL-2 mRNA (Fig. 1, lane 3 , cell line). The demonstration of transcription of IL-2 mRNA (5) confirmed that this agonist pair effectively activates both normal T cells and the quiescent GK606 cell line.
To establish whether or not PKA phosphotransferase activity occurs during the very early phase of T cell activation, we quantified PKA activity in T cells activated with anti-CD3-e and rIL-1 a over 60 min. Activated fresh T cells exhibited PKA activity at 1 min; the PKA phosphotransferase activity peaked 6.4-fold (245 pmol/min per mg protein) by 5 min and returned toward baseline (baseline, 38 pmol/min per mg) by 60 min (Fig. 2) . Increasing concentrations of anti-CD3-e (from 1 to 250 ng/ml) or rIL-Ia (from 5 to 500 U/ml) did not further increase PKA activity. Similarly, activation of the quiescent GK606 line with anti-CD3-E and rIL-l1a activated PKA at 1 min, which peaked 6.9-fold ( 195 pmol/min per mg) over baseline (28 pmol/min per mg) at 5 min and returned toward baseline (67 pmol/min per mg) by 60 min. Substitution of anti-CD4 for anti-CD3-e failed to activate PKA (Fig. 2) . Finally, neither 10 ng/ml anti-CD3-e nor 50-250 U/ml rIL-la (Fig. 2, lane 4) . To determine whether this agonist pair concomitantly activated PKA, fresh T cells were treated with 10 eightfold (243 pmol/min per mg) by 15 min, and returned toward baseline at 60 min (Fig. 2) . A bimodal curve with a minor peak at 5 min and a major peak at 15 min was consistently observed. However, ionomycin alone failed to stimulate PKA activity (data not shown). When the agonist pair anti-CD3-e and PMA was used, the peak PKA activity of fresh T cells occurred at an intermediate time of 10 min (data not shown). Thus, activation ofT cells via the TCR/CD3 complex and IL-IR or by direct stimulation of PKC and [Ca2+]i stimulated PKA phosphotransferase activity at 1 min. The times of peak PKA activity varied slightly, but consistently, depending on the agonists used to activate T cells.
PKA-I isozyme activity is an early event in Tcell activation. To determine whether there is preferential activation ofa PKA isozyme, primary T cells were cultured in the absence or presence of anti-CD3-E and rIL-1 a for 5 min; the cells were promptly sonicated at 4VC; and the cellular homogenates were fractionated via sequential DE52-cellulose and CM-sephadex chromatography. Table I shows the total phosphotransferase activities for the PKA-I and PKA-II isozymes as well as the free C subunit activities before and 5 min after T cell activation by anti-CD3-e and rIL-la in eight independent experiments. Compared with nonactivated T cells, there was a statistically significant, mean 42.1% decrease in PKA-I isozyme activity, a significant increase of 165% in free C subunit activity, but only a 7% change in PKA-II activity. The increase in PKA-II activity is not significantly different from PKA-II activity in nonactivated T cells. The preferential stimulation of the PKA-I isozyme resulted in a reduction of the ratio of PKA-I to PKA-II activity from 4 A representative experiment demonstrating preferential activation of the PKA-I isozyme after activation of T cells by anti-CD3-e and rIL-I a is shown in Fig. 3 . Nonactivated T cells had a total PKA-I activity of 528 pmol/min, a total PKA-II activity of 136 pmol/min, and a basal free C subunit activity of 78 pmol/min, yielding a ratio of PKA-I to PKA-II isozyme activity of 3.9:1. T cells activated for 5 min with anti-CD3-E and rIL-la showed a 41.3% reduction in PKA-I activity to 310 pmol/min, indicating activation of a portion of PKA-I by endogenous cAMP. Only a 9.5% increment in PKA-II isozyme activity was observed. The preferential stimulation of PKA-I resulted in a reduction ofthe ratio ofPKA-I to PKA-II activity to 2.0:1. The C subunit activity increased 210%, from 78 to 242 pmol/min, indicating that free C subunit was released from PKA-I after its activation.
The activation of fresh T cells by 10 ng/ml PMA and 0.5 juM ionomycin also activated the PKA-I isozyme. The data are shown in Table I . At 15 min after activation, there was a statistically significant, mean 52.5% reduction of PKA-I isozyme activity, a significant increase of 232% in free C subunit activity, but < 2% decrease in PKA-II isozyme activity. The change in PKA-II activity was not statistically significant. The activation of PKA-I resulted in a substantial reduction in the ratio of PKA-I to PKA-II activity to 1.9:1. Thus, the concomitant reduction in the ratio of PKA-I to PKA-II activity and elevation of free C subunit activity produced by either agonist pair demonstrates that the PKA-I isozyme is preferentially activated. Parallel experiments were performed with the quiescent GK606 cell line, which has a ratio ofPKA-I to PKA-II activity of4.0:1. Activation ofthe cell line by anti-CD3-E and rIL-la for 5 min resulted in a 46% reduction in PKA-I activity from 237 to 128 pmol/min, yielding a ratio ofPKA-I to PKA-II activity of 1.4:1. There was < 5% increase in the PKA-II activity. The free C subunit activity increased 109% from 63 to 132 pmol/ min. Similarly, activation of the cell line with 10 ng/ml PMA and 0.5 juM ionomycin for 15 min caused a 64% decline in the PKA-I isozyme activity to 85 pmol/min, giving a ratio of PKA-I to PKA-II activity of 1.1:1. No change in the PKA-II activity was observed. The mean free C subunit activity rose 370% to 297 pmol/min. The decline in PKA-I and increase in C subunit activities after activation of the cell line with both Eight independent experiments using primary T lymphocytes. * The total PKA phosphotransferase activity (PKA-I + PKA-II + C subunit) was 695 pmol/min for the nonactivated cells, 658 pmol/min for cells activated with anti-CD3-E + and rIL-I a, and 650 pmol/min for cells activated with PMA and ionomycin. Compared with nonactivated T cells, the percent decrease in total PKA phosphotransferase activity after activation with anti-CD3-E and rIL-la was 5.3 and after activation with PMA and ionomycin was 6.5. The differences in total PKA activities after ligand-induced T cell activation are not significantly different from that of nonactivated T cells. $ The activity is the total PKA-I or PKA-II phosphotransferase activity. The activities for the PKA-I and PKA II isozymes and free C subunit are given as the mean ± SEM. § Numbers in brackets are the ranges ofphosphotransferase activities or ofactivity ratios. 11 activity after activation with anti-CD3-e and rIL-la was experiment is representative of eight independent experi agonist pairs paralleled the changes observed in fresh T cells. Together, the data suggest that activation of T cells stimulates PKA-I phosphotransferase activity. The reduction of PKA-I activity, increase in free C subunit activity, and stable PKA-II activity after T cell activation by either agonist pair was not associated with a significant change in the total PKA phosphotransferase activity (Table I) (Table II ). These results demonstrate that PKA activation by he absence either agonist pair can be effectively inhibited. were gently Activation of the quiescent GK606 T cell line and fresh T flied to a 1-ml cells by either agonist pair induced transcription of IL-2 [ose column mRNA compared with the nonactivated T cell line or fresh T was eluted cells (Fig. 1 A, lanes 2-4; cell line) . f3-Actin mRNA expression olumns were was constitutively present and unaffected by the state of T cell bed in the activation in both the T cell line and fresh T cells (Fig. 1 B, 1 whereas the lanes 2-4; cell line) (n = 5 experiments each).
Lonactivated
The effect of inhibiting PKA activity by Rp-cAMPS on the tivity was 528 expression ofIL-2 mRNA after activation with anti-CD3-E and -n , and the rIL-I a was studied in the GK606 cell line. Inhibition of PKA e total PKA-I activation did not block expression of IL-2 mRNA (Fig. 1 A, s 149 pmol/ lane 5). By contrast, activation ofthe T cell line in the presence PKA-I ofH-7 totally blocked expression ofIL-2 mRNA (Fig. 1 A, lane  rith nonacti-7) . Similarly, activation of the T cell line by 10 ng/ml PMA )hotransferase and 0.5 ,uM ionomycin in the presence of Rp-cAMPS did not Values are means±SEM.
Protein (Fig. 1 A, lane 6) , whereas IL-2 mRNA expression in response to activation of the T cell line by PMA and ionomycin was completely inhibited by H-7 ( Fig. 1 A, lane 8) . Fig. 1 B demonstrates that j3-actin mRNA expression was unaffected by the inhibitors of PKA (RpcAMPS) or PKC (H-7) (lanes 5-8) . These results suggest that the activation of PKA-I does not appear to be required for the transcription of IL-2 mRNA.
PKA-I isozyme phosphorylates membrane-associated proteins. The very early activation of the PKA-I isozyme after T cell activation with both agonist pairs prompted us to determine whether proteins were phosphorylated by this isozyme. The PKA-I isozyme is predominantly associated with the plasma membrane of human T lymphocytes ( 12 ) . Thus, cells labeled with 32p; were treated for various intervals with 2.5 mM Bt2cAMP in the absence or presence of the cell-permeable cyclic nucleotide protein kinase inhibitor, H-8; plasma membrane was isolated; the membrane fragments were separated by 12% 1 -D PAGE; and autoradiographs were prepared ( 18) . The autoradiograph shown in figure 4 demonstrates PKA-I-catalyzed phosphorylation of several proteins, p 14.2, p17.7, p20.8, p21.6, p38.7, and p48. Phosphorylation was observed within 0.5 min. p17.7 shows increasing phosphorylation to 10 min and dephosphorylation at 20 min. H-8 inhibited PKA-I-catalyzed phosphorylation of membrane-associated proteins.
Discussion
The function ofPKA during the early biochemical events leading to the activation of human T lymphocytes has not been established. The recent recognition that the PKA-I isozyme is associated with the plasma membrane ( 12) raised the possibility that this isozyme may phosphorylate membrane-associated proteins required for early biochemical events and/or regulation of IL-2 gene transcription during T cell activation. The data presented herein demonstrate that treatment of either fresh human T cells or a quiescent, nonmalignant human CD4 + T cell line with the agonist pairs anti-CD3-E and rIL-1 a or PMA and ionomycin stimulated PKA phosphotransferase activity within 1 min.
The activation of PKA phosphortransferase activity in T cells depended on the presence ofboth anti-CD3-E and rIL-la. At the concentrations of the ligands used, PKA activation required the concomitant occupancy of both the IL-i R and TCR/CD3 complex by their respective ligands, for neither anti-CD3-E nor rIL-1 a alone provided a sufficient stimulus to activate the enzyme. Although concentrations of anti-CD3-E 100-fold greater can stimulate cAMP production, promote occupancy of cAMP receptors on PKA R subunits, and induce capping ofCD3 on normal T cells ( 18) , cells cannot proliferate without a costimulatory signal (5, 26) . Under the conditions used, rIL-I a provided the costimulatory signal and reduced the concentration of anti-CD3-E needed to stimulate PKA activation. Although our results concur with previous analyses that concluded that IL-1 provides a cooperative signal for normal human T cell activation (27) , our data indicate that IL-l a does not directly initiate a signal that traverses the AC/cAMP/PKA pathway in normal T cells. Interestingly, IL-l induces cAMP production and activation of an NF-KB-like DNA-binding protein in a human pre-B cell (28) and a human natural killer cell line (29), but neither increases cAMP nor activates NF-KB in a human T cell line (30, 31 ) . Our inability to detect PKA phosphotransferase activity after exposure of T cells to a wide range of rIL-1 a concentrations indirectly indicates that cAMP levels are not increased and would suggest that the cytokine probably initiates signals that traverse other pathways (30, 32) . Recent evidence implicating a novel G protein in the coupling of IL-I R to an alternative pathway (33) and the activation ofa protein tyrosine kinase(s) by IL-1 a in a murine T cell line (34) provide support for this thesis. Because IL-1 activates discrete biochemical pathways in different human and murine cell lines (28, 29, (31) (32) (33) (34) (35) (36) (37) , its precise mechanism of action in normal human T lymphocytes requires further analysis.
T cell activation was also induced by the agonist pair of PMA initiation of IL-2 mRNA transcription and, ultimately, T cell proliferation (4, 5, 38) . However, we observed that PMA and ionomycin also activated PKA. Although PMA alone activates PKC (38) , neither the Ca2+ ionophore nor the phorbol ester alone could activate PKA. When the data using both agonist pairs were pooled, it became apparent that effective activation of PKA requires either cross-linking of CD3-e by anti-CD3-E in the presence ofrIL-1 a or both the phorbol ester and ionophore.
Sequential DE52-cellulose and CM-sephadex column chromatography separates PKA into its constitutive PKA-I and PKA-II isozymes and captures the free, endogenous C subunit (20) . Using this technique, we demonstrated that the PKA activity observed between 1 and 5 min after activation of fresh T cells by either agonist pair was the result of preferential activation of the PKA-I isozyme. There was no significant change in the PKA-II activity. This result implies that the agonist pairs induce AC activation, yielding enhanced cAMP production and occupancy of RI subunits by cAMP. The activation and partial use of the PKA-I isozyme causes the ratio of PKA-I to PKA-II isozyme activity to drop significantly from 3.1:1-6.2:1 to 1.1:1-3.2:1. Similarly, activation of the GK606 line, a nonmalignant human CD4' T cell line, with both agonist pairs also produced a significant reduction in the PKA-I to PKA-II activity ratio. Because the reduction in PKA-I activity and concomitant increase in free C subunit activity were not associated with either a significant change in PKA-II activity or total PKA phosphotransferase activity, it is reasonable to conclude that the decline in PKA-I activity is due to the activation of a portion of the PKA-I holoenzyme, leaving the remaining isozyme in the holoenzyme form and resulting in the release of free C subunit.
The polyphosphoinositide/Ca2+/PKC pathway can also stimulate PKA activity in other cell types (39) (40) (41) (42) (43) (44) . This observation suggests that the polyphosphoinositide/Ca2+/PKC and AC/cAMP/PKA are interdependent pathways. Although the precise mechanism(s) by which PMA and ionomycin activate PKA-I isozyme activity in the human T lymphocyte is uncertain, three potential mechanisms could be operative. PKC could phosphorylate the C subunit of AC, directly activating the enzyme (42) . A second potential mechanism is by phosphorylation of the Gia subunit by PKC (45) . The a subunit of Gi inhibits AC catalysis; phosphorylation of Gia may block its inhibitory function ofAC, thereby permitting AC catalysis. Yet a third potential mechanism is the phosphorylation of the G,,a subunit by PKC (46) . Because the interdependence between the AC/cAMP/PKA and polyphosphoinositide/Ca2+/PKC pathways in T lymphocytes may be regulated, in part, by phosphorylation/dephosphorylation of receptor-associated G protein subunits, it will be of practical importance to define more precisely the mechanism of phorbol ester-induced PKA activation. Moreover, other, as-yet-unidentified, mechanisms could account for the apparent interdependence of the pathways.
PKA-I isozyme activation did not appear to be required for initiation of IL-2 gene transcription. Inhibition of PKA activity and, by inference, subsequent substrate phosphorylation, by Rp-cAMPS did not impede expression of IL-2 mRNA. By contrast, inhibition of PKC activity by H-7 totally blocked transcription of the IL-2 gene, but not the f-actin gene. These data suggest that PKA-I-catalyzed protein phosphorylation may not be directly involved in the initiation of IL-2 gene transcription. However, PKA-I did result in the immediate phosphorylation of multiple membrane-associated proteins with molecular masses between 14 and 48 kD. Although the identities of these protein substrates for PKA-I are not yet known, it is conceivable that one or more of these phosphoproteins may have a role in the very early events of T cell activation. Thus, identification of these proteins may provide insight into the specific role of PKA-I in early T cell activation events.
It is possible, however, that basal PKA activity may be necessary and is permissive for the transcription of IL-2 mRNA. The precedent for this supposition derives from experiments performed in the EL-4 and JEG-3 cell lines. In an analysis of the role ofIL-1 on activation ofthe AP-1 transcription factor in the EL-4 cell line, IL-1 alone neither increases intracellular cAMP levels nor induces AP-l DNA binding activity. However, the combination of IL-1 and a phorbol ester promotes AP-I activity in the absence ofa rise in cAMP levels. In spite of the absence of an apparent role for the AC/cAMP/ PKA pathway, transfection of a cDNA encoding a protein kinase inhibitor (PKI) specific for PKA into EL-4 cells abrogates the capacity of IL-1 and a phorbol ester to activate AP-1 DNA binding activity (36) . Similarly, in the JEG-3 cell line, expression ofthe human chorionic gonadotropin-a subunit gene also depends on basal PKA activity for transfection of plasmids encoding PKI abolishes transcription ofthe gene (47) . The > 92% inhibition of PKA phosphotransferase activity by Rp-cAMPS leaves basal PKA activity (Table II) . Thus, a role for basal PKA-dependent protein phosphorylation in the regulation ofIL-2 gene transcription cannot be entirely excluded.
In conclusion, this is the first demonstration that an isozyme of PKA is associated with the very early T cell activation events that ultimately result in mitosis and immune effector activities. Hence, the PKA-I isozyme could be regarded as an antigen-or mitogen-stimulated protein kinase that serves to phosphorylate membrane-associated proteins. Furthermore, this result implies that the PKA-I isozyme works in concert with other early-acting protein kinases, including the p59ffT and p56'ck tyrosine kinases (48) , and PKC isozymes (5) to convey a receptor-initiated signal to different subcellular compartments. The demonstration that PKA-I is associated with early signaling events revises the current concept that PKA conveys an "off" signal that ultimately inhibits mitosis and certain T cell effector activities such as IL-2 production and cytotoxicity ( 11 ) .
